▶ 調査レポート

世界のジルチアゼムHCl市場 2028年:純度≥99%、純度≥99.5%

• 英文タイトル:Global Diltiazem HCl Market Insights, Forecast to 2028

Global Diltiazem HCl Market Insights, Forecast to 2028「世界のジルチアゼムHCl市場 2028年:純度≥99%、純度≥99.5%」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C1087
• 出版社/出版日:QYResearch / 2022年7月8日
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のジルチアゼムHClの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジルチアゼムHClの世界市場のxxx%を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のジルチアゼムHClの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのジルチアゼムHCl市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのジルチアゼムHCl市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ジルチアゼムHClのグローバル主要メーカーには、Fermion、Orion Corporation、Fleming Laboratories、Chemeca Drugs、Lusochimica SpA、FIS、Mitsubishi Tanabe Pharma、Teva API、Divi's、Cambrex、Piramal Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ジルチアゼムHCl市場は、種類と用途によって区分されます。世界のジルチアゼムHCl市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99%、純度≥99.5%

【用途別セグメント】
注射液、錠剤、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ジルチアゼムHCl製品概要
- 種類別市場(純度≥99%、純度≥99.5%)
- 用途別市場(注射液、錠剤、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のジルチアゼムHCl販売量予測2017-2028
- 世界のジルチアゼムHCl売上予測2017-2028
- ジルチアゼムHClの地域別販売量
- ジルチアゼムHClの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ジルチアゼムHCl販売量
- 主要メーカー別ジルチアゼムHCl売上
- 主要メーカー別ジルチアゼムHCl価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(純度≥99%、純度≥99.5%)
- ジルチアゼムHClの種類別販売量
- ジルチアゼムHClの種類別売上
- ジルチアゼムHClの種類別価格
・用途別市場規模(注射液、錠剤、その他)
- ジルチアゼムHClの用途別販売量
- ジルチアゼムHClの用途別売上
- ジルチアゼムHClの用途別価格
・北米市場
- 北米のジルチアゼムHCl市場規模(種類別、用途別)
- 主要国別のジルチアゼムHCl市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのジルチアゼムHCl市場規模(種類別、用途別)
- 主要国別のジルチアゼムHCl市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のジルチアゼムHCl市場規模(種類別、用途別)
- 主要国別のジルチアゼムHCl市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のジルチアゼムHCl市場規模(種類別、用途別)
- 主要国別のジルチアゼムHCl市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのジルチアゼムHCl市場規模(種類別、用途別)
- 主要国別のジルチアゼムHCl市場規模(トルコ、サウジアラビア)
・企業情報
Fermion、Orion Corporation、Fleming Laboratories、Chemeca Drugs、Lusochimica SpA、FIS、Mitsubishi Tanabe Pharma、Teva API、Divi's、Cambrex、Piramal Pharma
・産業チェーン及び販売チャネル分析
- ジルチアゼムHClの産業チェーン分析
- ジルチアゼムHClの原材料
- ジルチアゼムHClの生産プロセス
- ジルチアゼムHClの販売及びマーケティング
- ジルチアゼムHClの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ジルチアゼムHClの産業動向
- ジルチアゼムHClのマーケットドライバー
- ジルチアゼムHClの課題
- ジルチアゼムHClの阻害要因
・主な調査結果

Market Analysis and Insights: Global Diltiazem HCl Market
Due to the COVID-19 pandemic, the global Diltiazem HCl market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Diltiazem HCl global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Diltiazem HCl market size is valued at US$ million in 2021, while the US and Europe Diltiazem HCl are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diltiazem HCl landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Diltiazem HCl include Fermion, Orion Corporation, Fleming Laboratories, Chemeca Drugs, Lusochimica SpA, FIS, Mitsubishi Tanabe Pharma, Teva API and Divi’s, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Diltiazem HCl capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Diltiazem HCl by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Diltiazem HCl Scope and Segment
Diltiazem HCl market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diltiazem HCl market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Injection Solution
Tablet
Other
By Company
Fermion
Orion Corporation
Fleming Laboratories
Chemeca Drugs
Lusochimica SpA
FIS
Mitsubishi Tanabe Pharma
Teva API
Divi’s
Cambrex
Piramal Pharma
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Diltiazem HCl Product Introduction
1.2 Market by Type
1.2.1 Global Diltiazem HCl Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Diltiazem HCl Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Tablet
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Diltiazem HCl Production
2.1 Global Diltiazem HCl Production Capacity (2017-2028)
2.2 Global Diltiazem HCl Production by Region: 2017 VS 2021 VS 2028
2.3 Global Diltiazem HCl Production by Region
2.3.1 Global Diltiazem HCl Historic Production by Region (2017-2022)
2.3.2 Global Diltiazem HCl Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Diltiazem HCl Sales in Volume & Value Estimates and Forecasts
3.1 Global Diltiazem HCl Sales Estimates and Forecasts 2017-2028
3.2 Global Diltiazem HCl Revenue Estimates and Forecasts 2017-2028
3.3 Global Diltiazem HCl Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Diltiazem HCl Sales by Region
3.4.1 Global Diltiazem HCl Sales by Region (2017-2022)
3.4.2 Global Sales Diltiazem HCl by Region (2023-2028)
3.5 Global Diltiazem HCl Revenue by Region
3.5.1 Global Diltiazem HCl Revenue by Region (2017-2022)
3.5.2 Global Diltiazem HCl Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Diltiazem HCl Production Capacity by Manufacturers
4.2 Global Diltiazem HCl Sales by Manufacturers
4.2.1 Global Diltiazem HCl Sales by Manufacturers (2017-2022)
4.2.2 Global Diltiazem HCl Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Diltiazem HCl in 2021
4.3 Global Diltiazem HCl Revenue by Manufacturers
4.3.1 Global Diltiazem HCl Revenue by Manufacturers (2017-2022)
4.3.2 Global Diltiazem HCl Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Diltiazem HCl Revenue in 2021
4.4 Global Diltiazem HCl Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Diltiazem HCl Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Diltiazem HCl Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Diltiazem HCl Sales by Type
5.1.1 Global Diltiazem HCl Historical Sales by Type (2017-2022)
5.1.2 Global Diltiazem HCl Forecasted Sales by Type (2023-2028)
5.1.3 Global Diltiazem HCl Sales Market Share by Type (2017-2028)
5.2 Global Diltiazem HCl Revenue by Type
5.2.1 Global Diltiazem HCl Historical Revenue by Type (2017-2022)
5.2.2 Global Diltiazem HCl Forecasted Revenue by Type (2023-2028)
5.2.3 Global Diltiazem HCl Revenue Market Share by Type (2017-2028)
5.3 Global Diltiazem HCl Price by Type
5.3.1 Global Diltiazem HCl Price by Type (2017-2022)
5.3.2 Global Diltiazem HCl Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Diltiazem HCl Sales by Application
6.1.1 Global Diltiazem HCl Historical Sales by Application (2017-2022)
6.1.2 Global Diltiazem HCl Forecasted Sales by Application (2023-2028)
6.1.3 Global Diltiazem HCl Sales Market Share by Application (2017-2028)
6.2 Global Diltiazem HCl Revenue by Application
6.2.1 Global Diltiazem HCl Historical Revenue by Application (2017-2022)
6.2.2 Global Diltiazem HCl Forecasted Revenue by Application (2023-2028)
6.2.3 Global Diltiazem HCl Revenue Market Share by Application (2017-2028)
6.3 Global Diltiazem HCl Price by Application
6.3.1 Global Diltiazem HCl Price by Application (2017-2022)
6.3.2 Global Diltiazem HCl Price Forecast by Application (2023-2028)
7 North America
7.1 North America Diltiazem HCl Market Size by Type
7.1.1 North America Diltiazem HCl Sales by Type (2017-2028)
7.1.2 North America Diltiazem HCl Revenue by Type (2017-2028)
7.2 North America Diltiazem HCl Market Size by Application
7.2.1 North America Diltiazem HCl Sales by Application (2017-2028)
7.2.2 North America Diltiazem HCl Revenue by Application (2017-2028)
7.3 North America Diltiazem HCl Sales by Country
7.3.1 North America Diltiazem HCl Sales by Country (2017-2028)
7.3.2 North America Diltiazem HCl Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Diltiazem HCl Market Size by Type
8.1.1 Europe Diltiazem HCl Sales by Type (2017-2028)
8.1.2 Europe Diltiazem HCl Revenue by Type (2017-2028)
8.2 Europe Diltiazem HCl Market Size by Application
8.2.1 Europe Diltiazem HCl Sales by Application (2017-2028)
8.2.2 Europe Diltiazem HCl Revenue by Application (2017-2028)
8.3 Europe Diltiazem HCl Sales by Country
8.3.1 Europe Diltiazem HCl Sales by Country (2017-2028)
8.3.2 Europe Diltiazem HCl Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Diltiazem HCl Market Size by Type
9.1.1 Asia Pacific Diltiazem HCl Sales by Type (2017-2028)
9.1.2 Asia Pacific Diltiazem HCl Revenue by Type (2017-2028)
9.2 Asia Pacific Diltiazem HCl Market Size by Application
9.2.1 Asia Pacific Diltiazem HCl Sales by Application (2017-2028)
9.2.2 Asia Pacific Diltiazem HCl Revenue by Application (2017-2028)
9.3 Asia Pacific Diltiazem HCl Sales by Region
9.3.1 Asia Pacific Diltiazem HCl Sales by Region (2017-2028)
9.3.2 Asia Pacific Diltiazem HCl Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Diltiazem HCl Market Size by Type
10.1.1 Latin America Diltiazem HCl Sales by Type (2017-2028)
10.1.2 Latin America Diltiazem HCl Revenue by Type (2017-2028)
10.2 Latin America Diltiazem HCl Market Size by Application
10.2.1 Latin America Diltiazem HCl Sales by Application (2017-2028)
10.2.2 Latin America Diltiazem HCl Revenue by Application (2017-2028)
10.3 Latin America Diltiazem HCl Sales by Country
10.3.1 Latin America Diltiazem HCl Sales by Country (2017-2028)
10.3.2 Latin America Diltiazem HCl Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diltiazem HCl Market Size by Type
11.1.1 Middle East and Africa Diltiazem HCl Sales by Type (2017-2028)
11.1.2 Middle East and Africa Diltiazem HCl Revenue by Type (2017-2028)
11.2 Middle East and Africa Diltiazem HCl Market Size by Application
11.2.1 Middle East and Africa Diltiazem HCl Sales by Application (2017-2028)
11.2.2 Middle East and Africa Diltiazem HCl Revenue by Application (2017-2028)
11.3 Middle East and Africa Diltiazem HCl Sales by Country
11.3.1 Middle East and Africa Diltiazem HCl Sales by Country (2017-2028)
11.3.2 Middle East and Africa Diltiazem HCl Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Fermion
12.1.1 Fermion Corporation Information
12.1.2 Fermion Overview
12.1.3 Fermion Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Fermion Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Fermion Recent Developments
12.2 Orion Corporation
12.2.1 Orion Corporation Corporation Information
12.2.2 Orion Corporation Overview
12.2.3 Orion Corporation Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Orion Corporation Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Orion Corporation Recent Developments
12.3 Fleming Laboratories
12.3.1 Fleming Laboratories Corporation Information
12.3.2 Fleming Laboratories Overview
12.3.3 Fleming Laboratories Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Fleming Laboratories Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Fleming Laboratories Recent Developments
12.4 Chemeca Drugs
12.4.1 Chemeca Drugs Corporation Information
12.4.2 Chemeca Drugs Overview
12.4.3 Chemeca Drugs Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Chemeca Drugs Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Chemeca Drugs Recent Developments
12.5 Lusochimica SpA
12.5.1 Lusochimica SpA Corporation Information
12.5.2 Lusochimica SpA Overview
12.5.3 Lusochimica SpA Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Lusochimica SpA Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Lusochimica SpA Recent Developments
12.6 FIS
12.6.1 FIS Corporation Information
12.6.2 FIS Overview
12.6.3 FIS Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 FIS Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 FIS Recent Developments
12.7 Mitsubishi Tanabe Pharma
12.7.1 Mitsubishi Tanabe Pharma Corporation Information
12.7.2 Mitsubishi Tanabe Pharma Overview
12.7.3 Mitsubishi Tanabe Pharma Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Mitsubishi Tanabe Pharma Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Mitsubishi Tanabe Pharma Recent Developments
12.8 Teva API
12.8.1 Teva API Corporation Information
12.8.2 Teva API Overview
12.8.3 Teva API Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Teva API Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Teva API Recent Developments
12.9 Divi’s
12.9.1 Divi’s Corporation Information
12.9.2 Divi’s Overview
12.9.3 Divi’s Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Divi’s Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Divi’s Recent Developments
12.10 Cambrex
12.10.1 Cambrex Corporation Information
12.10.2 Cambrex Overview
12.10.3 Cambrex Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Cambrex Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Cambrex Recent Developments
12.11 Piramal Pharma
12.11.1 Piramal Pharma Corporation Information
12.11.2 Piramal Pharma Overview
12.11.3 Piramal Pharma Diltiazem HCl Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Piramal Pharma Diltiazem HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Piramal Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Diltiazem HCl Industry Chain Analysis
13.2 Diltiazem HCl Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Diltiazem HCl Production Mode & Process
13.4 Diltiazem HCl Sales and Marketing
13.4.1 Diltiazem HCl Sales Channels
13.4.2 Diltiazem HCl Distributors
13.5 Diltiazem HCl Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Diltiazem HCl Industry Trends
14.2 Diltiazem HCl Market Drivers
14.3 Diltiazem HCl Market Challenges
14.4 Diltiazem HCl Market Restraints
15 Key Finding in The Global Diltiazem HCl Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer